Physician and Patient Influences on Provider Performance: &bgr;-Blockers in Postmyocardial Infarction Management in the MI-Plus Study

Background— Efforts to improve the quality of care for patients with cardiovascular disease frequently target the decrease of physician-level performance variability. We assessed how variability in providing &bgr;-blockers to ambulatory postmyocardial infarction (MI) patients was influenced by physician and patient level characteristics. Methods and Results— &bgr;-Blocker prescription and patient characteristics were abstracted from charts of post-MI patients treated by 133 primary care physicians between 2003 and 2007 and linked to physician and practice characteristics. Associations of &bgr;-blocker prescription with physician- and patient-level characteristics were examined using mixed-effects models, with physician-level effects as random. Mean physician-specific predicted probabilities and the intraclass correlations, which assessed the proportion of variance explainable at the physician level, were estimated. Of 1901 patients without major contraindication, 69.1% (range across physicians, 20% to 100%) were prescribed &bgr;-blockers. Prescription varied with comorbidity from 78.3% in patients with chronic kidney disease to 54.7% for patients with stroke. Although physician characteristics such as older physician age, group practice, and rural location were each positively associated with &bgr;-blocker prescription, physician factors accounted for only 5% to 8% of the variance in &bgr;-blocker prescription; the preponderance of the variance, 92% to 95%, was at the patient level. The mean physician-specific probability of &bgr;-blocker prescription (95% confidence interval) in the fully adjusted model was 63% (61% to 65%). Conclusions— &bgr;-Blocker prescription rates were surprisingly low. The contribution of physician factors to overall variability in &bgr;-blocker prescription, however, was limited. Increasing evidence-based use of &bgr;-blockers may not be accomplished by focusing mostly on differential performance across physicians.

[1]  E. Funkhouser,et al.  Characteristics that predict physician participation in a Web‐based CME activity: The MI‐Plus study , 2009, The Journal of continuing education in the health professions.

[2]  K. Anstrom,et al.  Alabama coronary artery bypass grafting project: results of a statewide quality improvement initiative. , 2001, JAMA.

[3]  Rodney A Hayward,et al.  Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. , 2002, Health services research.

[4]  P. Austin,et al.  Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction , 2008, Canadian Medical Association Journal.

[5]  R. Collins,et al.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.

[6]  A D Oxman,et al.  Audit and feedback: effects on professional practice and health care outcomes. , 2006, The Cochrane database of systematic reviews.

[7]  Guang Guo,et al.  Multilevel Modeling for Binary Data , 2000 .

[8]  G. Bakris Role for beta-blockers in the management of diabetic kidney disease. , 2003, American journal of hypertension.

[9]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[10]  W. Manning,et al.  The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. , 1999, JAMA.

[11]  Peter W. Tuerk,et al.  Estimating Physician Effects on Glycemic Control in the Treatment of Diabetes , 2008, Diabetes Care.

[12]  Robert Fletcher,et al.  Systematic Review: The Relationship between Clinical Experience and Quality of Health Care , 2005, Annals of Internal Medicine.

[13]  S. Schneeweiss,et al.  Adherence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarction: A Population-Based Natural Experiment , 2007, Circulation.

[14]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[15]  A. Ropper,et al.  Clinical Experience and Quality of Health Care , 2005, Annals of Internal Medicine.

[16]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[17]  Thomas H. Lee Eulogy for a quality measure. , 2007, The New England journal of medicine.

[18]  Paul E. Johnson,et al.  Variation in Quality of Diabetes Care at the Levels of Patient, Physician, and Clinic , 2007, Preventing chronic disease.

[19]  K. Weiss,et al.  Performance measurement through audit, feedback, and profiling as tools for improving clinical care. , 2000, Chest.

[20]  Angela Fagerlin,et al.  Correlates of Between-Surgeon Variation in Breast Cancer Treatments , 2006, Medical care.

[21]  John Hsu,et al.  Meaningful Variation in Performance: A Systematic Literature Review , 2010, Medical care.

[22]  J. Allison,et al.  Are Co-Morbidities Associated with Guideline Adherence? The MI-Plus Study of Medicare Patients , 2009, Journal of General Internal Medicine.

[23]  Peter Davis,et al.  How much variation in clinical activity is there between general practitioners? A multi-level analysis of decision-making in primary care , 2002, Journal of health services research & policy.

[24]  Helen Y. Lee,et al.  Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge , 2008, Journal of managed care pharmacy : JMCP.

[25]  J. Selby,et al.  Meaningful Variation in Performance: What Does Variation in Quality Tell Us About Improving Quality? , 2010, Medical care.

[26]  Roel Bosker,et al.  Multilevel analysis : an introduction to basic and advanced multilevel modeling , 1999 .

[27]  F. Zacharias Beta blockers in hypertension. , 1973, Bruxelles medical.

[28]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[29]  G. Bakris,et al.  Beta blockers in the management of chronic kidney disease. , 2006, Kidney international.

[30]  C. O'connor The new heart failure guidelines: strategies for implementation. , 2007, American heart journal.

[31]  H. Krumholz,et al.  Association of early follow-up after acute myocardial infarction with higher rates of medication use. , 2008, Archives of internal medicine.

[32]  Freda Kemp Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences , 2003 .

[33]  R. Gliklich,et al.  Get with the guidelines for cardiovascular secondary prevention: pilot results. , 2004, Archives of internal medicine.

[34]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[35]  Sheldon Greenfield,et al.  Profiling Care Provided by Different Groups of Physicians: Effects of Patient Case-Mix (Bias) and Physician-Level Clustering on Quality Assessment Results , 2002, Annals of Internal Medicine.